Get the latest news on LAEKNA INC by LAEKNA INC. stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on LAEKF performance

Latest LAEKNA INC by LAEKNA INC. Stock News | OTC:LAEKF | Benzinga

LAEKNA INC by LAEKNA INC.

<ul><li>A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models</li><li>Significantly accelerated the progress of drug discovery leveraging cutting-edge AI models</li><li>Another potential anti-tumor drug candidate, LAE118 (a mutant-selective PI3Kα inhibitor) also in IND-enabling studies</li></ul><p>Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors.</p>

Comments

LAEKNA INC by LAEKNA INC. Stock News

News

Latest LAEKNA INC by LAEKNA INC. Stock News | OTC:LAEKF | Benzinga

Tuesday, March 04, 2025

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga